Antibody to peptidoglycan recognition protein (PGLYRP)-2 as a novel biomarker in rheumatoid arthritis.

CONCLUSIONS: Autoantibody against PGLYRP-2 was identified as a promising biomarker in RA, especially in early and seronegative patients.
PMID: 33427621 [PubMed - as supplied by publisher]

Source: Clinical and Experimental Rheumatology - January 13, 2021 Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research